tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RNAC Stock Latest News

Buy Rating for Cartesian Therapeutics: Promising Advancements in Biopharmaceuticals and Strategic Clinical Progress
RatingsBuy Rating for Cartesian Therapeutics: Promising Advancements in Biopharmaceuticals and Strategic Clinical Progress
14d ago
RNAC
Cartesian price target lowered to $40 from $45 at H.C. Wainwright
PremiumThe Fly
Cartesian price target lowered to $40 from $45 at H.C. Wainwright
16d ago
RNAC
Cartesian Therapeutics Faces Financial Risk from Goodwill and Intangible Asset Impairments Post-Merger
PremiumCompany Announcements
Cartesian Therapeutics Faces Financial Risk from Goodwill and Intangible Asset Impairments Post-Merger
17d ago
RNAC
Cartesian Therapeutics Advances mRNA Therapy Pipeline
PremiumCompany Announcements
Cartesian Therapeutics Advances mRNA Therapy Pipeline
17d ago
RNAC
Buy Rating for Cartesian Therapeutics: Promising Clinical Developments and Strong Financial Position
PremiumRatings
Buy Rating for Cartesian Therapeutics: Promising Clinical Developments and Strong Financial Position
17d ago
RNAC
Amgen data ‘muddies’ outlook for Cartesian, says Oppenheimer
PremiumThe FlyAmgen data ‘muddies’ outlook for Cartesian, says Oppenheimer
17d ago
AMGN
RNAC
Cartesian Therapeutics reports FY24 EPS ($4.49) vs. ($49.76) last year
Premium
The Fly
Cartesian Therapeutics reports FY24 EPS ($4.49) vs. ($49.76) last year
17d ago
RNAC
Cartesian Therapeutics sees cash runway into mid-2027
Premium
The Fly
Cartesian Therapeutics sees cash runway into mid-2027
17d ago
RNAC
Cartesian Therapeutics announces employment inducement grant
PremiumThe Fly
Cartesian Therapeutics announces employment inducement grant
24d ago
RNAC
Is RNAC a Buy, Before Earnings?
PremiumPre-Earnings
Is RNAC a Buy, Before Earnings?
27d ago
RNAC
Cartesian Therapeutics Advances Descartes-08 in Clinical Trials
PremiumCompany Announcements
Cartesian Therapeutics Advances Descartes-08 in Clinical Trials
27d ago
8K
RNAC
Innovative mRNA-Based CAR-T Therapy Positions Cartesian Therapeutics for Market Leadership
PremiumRatings
Innovative mRNA-Based CAR-T Therapy Positions Cartesian Therapeutics for Market Leadership
1M ago
RNAC
Cartesian Therapeutics announces new employment inducement grants
PremiumThe FlyCartesian Therapeutics announces new employment inducement grants
2M ago
RNAC
Cartesian Therapeutics announces FDA SPA agreement for Phase 3 AURORA trial
Premium
The Fly
Cartesian Therapeutics announces FDA SPA agreement for Phase 3 AURORA trial
2M ago
RNAC
Cartesian Therapeutics Sets 2025 Strategy for Descartes-08
Premium
Company Announcements
Cartesian Therapeutics Sets 2025 Strategy for Descartes-08
3M ago
8K
RNAC
Cartesian Therapeutics highlights progress, 2025 strategic priorities
PremiumThe Fly
Cartesian Therapeutics highlights progress, 2025 strategic priorities
3M ago
RNAC
Cartesian Therapeutics announces employment inducement grants
PremiumThe Fly
Cartesian Therapeutics announces employment inducement grants
3M ago
RNAC
Cartesian Therapeutics initiated with a Buy at BTIG
PremiumThe Fly
Cartesian Therapeutics initiated with a Buy at BTIG
3M ago
RNAC
Cartesian Therapeutics announces employment inducement grants
PremiumThe Fly
Cartesian Therapeutics announces employment inducement grants
3M ago
RNAC
Cartesian Therapeutics files to sell 11.39M shares of common stock for holders
PremiumThe FlyCartesian Therapeutics files to sell 11.39M shares of common stock for holders
4M ago
RNAC
Cartesian Therapeutics files to sell 6.25M shares of common stock for holders
Premium
The Fly
Cartesian Therapeutics files to sell 6.25M shares of common stock for holders
4M ago
RNAC
Cartesian Therapeutics files $400M mixed securities shelf
Premium
The Fly
Cartesian Therapeutics files $400M mixed securities shelf
4M ago
RNAC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >